UK Markets open in 2 hrs 45 mins
  • NIKKEI 225

    26,427.82
    +130.96 (+0.50%)
     
  • HANG SENG

    26,688.94
    +19.19 (+0.07%)
     
  • CRUDE OIL

    45.93
    +0.22 (+0.48%)
     
  • GOLD FUTURES

    1,809.20
    +3.70 (+0.20%)
     
  • DOW

    29,872.47
    -173.77 (-0.58%)
     
  • BTC-GBP

    13,350.90
    -599.80 (-4.30%)
     
  • CMC Crypto 200

    349.09
    -21.43 (-5.78%)
     
  • Nasdaq

    12,094.40
    +57.62 (+0.48%)
     
  • ^FTAS

    3,607.81
    -25.54 (-0.70%)
     

NI Reports Third Quarter Results

·16-min read

Revenue of $308 million, above midpoint of guidance

Q3 2020 Summary

  • GAAP Revenue of $308 million, down 9 percent year over year

  • Fully diluted GAAP EPS of $(0.04) and fully diluted non-GAAP EPS of $0.23

  • EBITDA of $19 million for the third quarter

  • Cash and short-term investments of $290 million as of September 30, 2020

First Three Quarters of 2020 Summary

  • GAAP Revenue of $919 million, down 7 percent year over year

  • Fully diluted GAAP EPS of $1.06 and fully diluted non-GAAP EPS of $0.74

  • EBITDA of $242 million for the first nine months of 2020

National Instruments (Nasdaq: NATI) today announced Q3 2020 revenue of $308 million, down 9 percent year over year, and up 2 percent sequentially.

In Q3 2020 the value of the company's orders was down 7 percent year over year; orders over $20,000 were down 4 percent year over year; and orders under $20,000 were down 11 percent year over year. For Q3, year over year orders in the Americas region were relatively flat, in EMEA orders were down 16 percent, and in APAC orders were down 7 percent during the quarter.

Before the second quarter of 2020 we included order value and net sales attributable to our operations in India within the EMEA region. In the second quarter of 2020, we began including these amounts within the APAC geographic region, to reflect recent changes within our organizational structure.

Geographic revenue in U.S. dollar terms for Q3 2020 compared with Q3 2019 was down 11 percent in the Americas, down 5 percent in APAC and down 12 percent in EMEA. Excluding the impact of foreign currency exchange, revenue was down 11 percent in the Americas, down 3 percent in APAC and down 13 percent in EMEA. Historical revenue from these three regions can be found on NI’s investor website at www.ni.com/nati.

In Q3, GAAP gross margin was 70 percent and non-GAAP gross margin was 74 percent. Total GAAP operating expenses were $218 million, up 1 percent year over year. Total non-GAAP operating expenses were down 3 percent year over year at $189 million. GAAP operating loss was $(2) million with non-GAAP operating income of $40 million. GAAP net loss for Q3 was $(5) million and non-GAAP net income was $30 million, with GAAP fully diluted EPS of ($0.04) and non-GAAP fully diluted EPS of $0.23, above the midpoint of our guidance. EBITDA, or Earnings Before Interest, Taxes, Depreciation and Amortization, was $19 million for Q3.

For the first nine months of 2020, GAAP revenue was $919 million, down 7 percent year over year, the value of the company's total orders was down 6 percent year over year, with GAAP net income of $139 million, up 34% year over year, and GAAP fully diluted EPS of $1.06.

"We have and will continue to take a broad range of actions to ignite growth. Building on our unique software position, we believe we have the opportunity to once again modernize and disrupt our industry," said Eric Starkloff, NI CEO. "We remain focused on execution in the areas of our business that can drive our growth even within the constraints of an overall weaker spending environment. The actions we are taking, on both reductions and investments, are focused on achieving long-term growth."

"We delivered third quarter revenue above the midpoint of guidance despite the current economic environment. While we have seen positive signs in our business, we remain cautious to the uncertainty that lies ahead," said Karen Rapp, NI CFO. "We remain committed to the execution of our growth and profitability strategy in pursuit of our long-term financial targets. We believe our strong balance sheet and cash position provide us the capability to keep our capital allocation priorities unchanged as we stay committed to shareholder value."

As of September 30, 2020, NI had $290 million in cash and short-term investments. During the third quarter, NI paid $34 million in dividends and repurchased 446,502 shares of our common stock at an average price of $34.86 per share. The NI Board of Directors approved a quarterly dividend of $0.26 per share payable on December 7, 2020, to stockholders of record on November 16, 2020.

The company’s non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the company’s GAAP and non-GAAP results are included as part of this news release.

Guidance

NI currently expects Q4 GAAP revenue to be in the range of $333 million to $363 million and Q4 non-GAAP revenue, which adjusts for the impact of purchase price accounting related to OptimalPlus, to be in the range of $335 million to $365 million. The company currently expects that GAAP fully diluted EPS will be in the range of $(0.04) to $0.10 for Q4, with non-GAAP fully diluted EPS expected to be in the range of $0.32 to $0.46. Included in our EPS guidance is a restructuring charge of $0.13 which relates to a reduction in our global workforce of approximately 9%.

Conference Call Information

Interested parties can listen to the Q3 2020 earnings conference call with NI management today, October 29, at 4:00 p.m. CT at ni.com/call or by dialing 855-212-2361 and entering confirmation code 7456239 ten minutes prior to the call start time. Replay information is available by calling (855) 859-2056 and entering confirmation code 7456239 , shortly after the call through November 1 at 10:00 p.m. CT or by visiting the company’s website at ni.com/call.

Non-GAAP Presentation

In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its revenue, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income and fully diluted EPS for the three and nine months ended September 30, 2020 and 2019, on a GAAP and non-GAAP basis. NI is also providing guidance on its non-GAAP revenue and non-GAAP fully diluted EPS.

When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company’s operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider purchase accounting fair value adjustments, stock-based compensation expense, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods; to establish operational goals; to compare with its business plan and individual operating budgets; to measure management performance for the purposes of executive compensation, including payments to be made under bonus plans; to assist the public in measuring the company’s performance relative to the company’s long-term public performance goals; to allocate resources; and, relative to the company’s historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.

This news release discloses the company’s EBITDA for the three and nine months ended September 30, 2020 and 2019. The company believes that including the EBITDA results assists investors in assessing the company’s operational performance relative to its competitors. A reconciliation of EBITDA to GAAP net income is included with this news release.

Forward-Looking Statements

This release contains "forward-looking statements" including statements regarding we have and will continue to take a broad range of actions to ignite growth; building on our unique software position, we believe we have the opportunity to once again modernize and disrupt our industry; we remain focused on execution in the areas of our business that can drive our growth even within the constraints of an overall weaker spending environment; the actions we are taking, on both reductions and investments, are focused on achieving long-term growth; while we have seen positive signs in our business, we remain cautious to the uncertainty that lies ahead; we remain committed to the execution of our growth and profitability strategy in pursuit of our long-term financial targets; we believe our strong balance sheet and cash position provide us the capability to keep our capital allocation priorities unchanged as we stay committed to shareholder value; expecting Q4 GAAP revenue to be in the range of $333 million to $363 million, expecting Q4 non-GAAP revenue, which adjusts for the impact of purchase accounting fair value adjustments related to OptimalPlus, to be in the range of $335 million to $365 million, and expecting that GAAP fully diluted EPS will be in the range of $(0.04) to $0.10 for Q4, with non-GAAP fully diluted EPS expected to be in the range of $0.32 to $0.46; and included in our EPS guidance is a restructuring charge of $0.13 which relates to a reduction in our global workforce of approximately 9%. These statements are subject to a number of risks and uncertainties, including risks and uncertainties related to the COVID-19 virus and further economic and market disruptions resulting from COVID-19; further adverse changes or fluctuations in the global economy; further adverse fluctuations in our industry; foreign exchange fluctuations; changes in the current global trade regulatory environment; fluctuations in customer demands and markets; fluctuations in demand for NI products including orders from NI’s large customers; component shortages; delays in the release of new products; NI’s ability to effectively manage its operating expenses; manufacturing inefficiencies and the level of capacity utilization; the impact of any recent or future acquisitions or divestitures by NI (including the ability to successfully operate or integrate the acquired company’s business into NI, the ability to retain and integrate the acquired company’s employees into NI, and the ability to realize the expected benefits of the acquisition); NI’s ability to achieve the benefits of employee restructuring plans and possible changes in the size and timing of the related charges; expense overruns; and adverse effects of price changes or effective tax rates. Actual results may differ materially from the expected results. The company directs readers to its Form 10-K for the year ended Dec. 31, 2019, its Form 10-Q for the quarter ended June 30, 2020 and the other documents it files with the SEC for other risks associated with the company’s future performance. These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.

All information in this release is as of the date above. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company’s expectations.

About NI

At NI, we bring together the people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day. (NATI-F)

LabVIEW, National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.

National Instruments

Condensed Consolidated Balance Sheets

(in thousands)

September 30,

December 31,

2020

2019

(unaudited)

Assets

Current assets:

Cash and cash equivalents

$

197,319

$

194,616

Short-term investments

92,853

237,983

Accounts receivable, net

214,620

248,872

Inventories, net

209,558

200,410

Prepaid expenses and other current assets

72,956

65,477

Total current assets

787,306

947,358

Property and equipment, net

253,073

243,717

Goodwill

487,101

262,242

Intangible assets, net

183,067

84,083

Operating lease right-of-use assets

69,395

70,407

Other long-term assets

63,930

44,082

Total assets

$

1,843,872

$

1,651,889

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable and accrued expenses

$

48,886

$

52,192

Accrued compensation

53,496

47,732

Deferred revenue - current

116,871

131,445

Operating lease liabilities - current

16,177

13,431

Other taxes payable

41,604

40,607

Debt, current

3,500

Other current liabilities

50,259

20,716

Total current liabilities

330,793

306,123

Deferred income taxes

41,514

14,065

Liability for uncertain tax positions

6,867

6,652

Income tax payable - non-current

61,628

69,151

Deferred revenue - non-current

34,210

33,480

Operating lease liabilities - non-current

37,767

40,650

Debt, noncurrent

84,289

Other long-term liabilities

7,606

5,418

Total liabilities

$

604,674

$

475,539

Stockholders' equity:

Common stock

1,312

1,305

Additional paid-in capital

1,012,656

953,578

Retained earnings

247,970

242,537

Accumulated other comprehensive loss

(22,740

)

(21,070

)

Total stockholders' equity

1,239,198

1,176,350

Total liabilities and stockholders' equity

$

1,843,872

$

1,651,889

National Instruments

Condensed Consolidated Statements of Income

(in thousands, except per share data, unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Net sales:

Product

$

269,651

$

305,247

$

809,890

$

882,747

Software maintenance

38,473

35,195

108,944

103,000

Total net sales

308,124

340,442

918,834

985,747

Cost of sales:

Product

88,370

84,127

254,236

240,056

Software maintenance

3,893

1,788

7,689

5,700

Total cost of sales

92,263

85,915

261,925

245,756

Gross profit

215,861

254,527

656,909

739,991

70.1

%

74.8

%

71.5

%

75.1

%

Operating expenses:

Sales and marketing

109,774

113,922

330,939

352,340

Research and development

70,802

66,558

206,648

200,981

General and administrative

37,431

35,711

92,980

92,639

Total operating expenses

218,007

216,191

630,567

645,960

Gain on sale of business/assets

26,842

159,753

26,842

Operating income

(2,146

)

65,178

186,095

120,873

Other (expense) income:

(2,001

)

2,249

(2,584

)

5,379

Income before income taxes

(4,147

)

67,427

183,511

126,252

Provision for income taxes

475

15,783

44,588

22,697

Net (loss) income

$

(4,622

)

$

51,644

$

138,923

$

103,555

Basic (loss) earnings per share

$

(0.04

)

$

0.39

$

1.06

$

0.79

Diluted (loss) earnings per share

$

(0.04

)

$

0.39

$

1.06

$

0.78

Weighted average shares outstanding -

Basic

131,419

131,385

131,017

131,896

Diluted

131,419

131,889

131,671

132,890

Dividends declared per share

$

0.26

$

0.25

$

0.78

$

0.75

Condensed Consolidated Statements of Cash Flows

(in thousands, unaudited)

Nine Months Ended September 30,

2020

2019

Cash flow from operating activities:

Net income

$

138,923

$

103,555

Adjustments to reconcile net income to net cash provided by operating activities:

Disposal gains on sale of business/asset

(159,753

)

(26,842

)

Depreciation and amortization

61,228

54,546

Stock-based compensation

42,556

38,054

Deferred income taxes

(932

)

(1,461

)

Net change in operating assets and liabilities

26,762

(18,507

)

Net cash provided by operating activities

108,784

149,345

Cash flow from investing activities:

Acquisitions, net of cash received

(334,981

)

Capital expenditures

(36,573

)

(47,183

)

Proceeds from sale of business/assets, net of cash divested

160,266

32,492

Capitalization of internally developed software

(2,806

)

(7,179

)

Additions to other intangibles

(1,045

)

(1,132

)

Acquisitions of equity-method investments

(7,502

)

(13,670

)

Purchases of short-term investments

(206,330

)

(141,074

)

Sales and maturities of short-term investments

351,597

204,046

Net cash (used in) provided by investing activities

(77,374

)

26,300

Cash flow from financing activities:

Proceeds from revolving loan facility

20,000

Proceeds from term loan

70,000

Payments on term loan

(875

)

Debt issuance costs

(1,480

)

Proceeds from issuance of common stock

24,971

25,823

Repurchase of common stock

(39,244

)

(137,171

)

Dividends paid

(102,396

)

(99,083

)

Net cash used in financing activities

(29,024

)

(210,431

)

Impact of changes in exchange rates on cash

317

(1,827

)

Net change in cash and cash equivalents

2,703

(36,613

)

Cash and cash equivalents at beginning of period

194,616

259,386

Cash and cash equivalents at end of period

$

197,319

$

222,773

The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction and integration costs, capitalization and amortization of internally developed software costs, restructuring charges, gains on sale of business/assets, and other that were recorded in the line items indicated below (unaudited) (in thousands)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Stock-based compensation

Cost of sales

$

1,051

$

904

$

2,787

$

2,587

Sales and marketing

5,184

5,231

16,826

14,745

Research and development

4,692

4,099

12,640

12,029

General and administrative

4,293

3,158

10,301

8,693

Provision for income taxes

(3,854

)

(2,128

)

(8,260

)

(7,904

)

Total

$

11,366

$

11,264

$

34,294

$

30,150

Amortization of acquisition-related intangibles and fair value adjustments

Net sales

$

1,299

$

$

1,299

$

Cost of sales

4,198

833

5,579

2,525

Sales and marketing

2,334

492

3,300

1,485

Research and development

28

28

84

84

Other expense (income)

121

124

363

285

Provision for income taxes

(1,658

)

(190

)

(1,948

)

(576

)

Total

$

6,322

$

1,287

$

8,677

$

3,803

Acquisition transaction and integration costs, restructuring charges, and other(1)(2)(3)

Cost of sales

$

(13

)

$

$

7

$

Sales and marketing

1,158

2,993

8,771

8,290

Research and development

374

...

244

5,190

899

General and administrative(1)(3)

10,210

7,998

12,595

9,525

Gain on sale of business/assets(1)(2)

(26,842

)

(159,753

)

(26,842

)

Other expense (income)

270

397

Provision for income taxes

(712

)

3,090

33,965

1,240

Total

$

11,287

$

(12,517

)

$

(98,828

)

$

(6,888

)

(1): During the third quarter of 2019, the company recognized a gain of $27 million related to the sale of an office building, presented within "Gain on sale of business/assets". The company also recognized a charitable contribution expense of $7 million related to an infrequent donation using a portion of the proceeds from the sale of the building, presented within "General and administrative".

(2): During the first quarter of 2020, the company recognized a gain of $160 million related to the divestiture of AWR, presented within "Gain on sale of business/assets".

(3): During the third quarter of 2020, we recognized $5 million of compensation expense related to the replacement of unvested options acquired from OptimalPlus. These amounts were accounted for as post-combination expense and will be recognized over the required service period.

Capitalization and amortization of internally developed software costs

Cost of sales

$

6,769

$

6,954

$

20,995

$

20,073

Research and development

302

(2,682

)

(2,794

)

(7,179

)

Provision for income taxes

(1,485

)

(897

)

(3,822

)

(2,708

)

Total

$

5,586

$

3,375

$

14,379

$

10,186

National Instruments

Reconciliation of GAAP to Non-GAAP Measures

(in thousands, unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Reconciliation of Net sales to Non-GAAP Net sales

Net sales, as reported

$

308,124

340,442

918,834

$

985,747

plus: Impact of purchase accounting fair value adjustments

1,299

1,299

Non-GAAP net sales

$

309,423

340,442

920,133

$

985,747

Reconciliation of Gross Profit to Non-GAAP Gross Profit

Gross profit, as reported

$

215,861

$

254,527

$

656,909

$

739,991

Stock-based compensation

1,051

904

2,787

2,587

Amortization of acquisition-related intangibles and fair value adjustments

5,497

833

6,878

2,525

Acquisition transaction and integration costs, restructuring charges and other

(13

)

7

Amortization of internally developed software costs

6,769

6,954

20,995

20,073

Non-GAAP gross profit

$

229,165

$

263,218

$

687,576

$

765,176

Non-GAAP gross margin

74.1

%

77.3

%

74.7

%

77.6

%

Reconciliation of Operating Expenses to Non-GAAP Operating Expenses

Operating expenses, as reported

$

218,007

$

216,191

$

630,567

$

645,960

Stock-based compensation

(14,169

)

(12,488

)

(39,767

)

(35,467

)

Amortization of acquisition-related intangibles and fair value adjustments

(2,362

)

(520

)

(3,384

)

(1,569

)

Acquisition transaction and integration costs, restructuring charges and other

(11,742

)

(11,235

)

(26,556

)

(18,714

)

Capitalization of internally developed software costs

(302

)

2,682

2,794

7,179

Non-GAAP operating expenses

$

189,432

$

194,630

$

563,654

$

597,389

Reconciliation of Operating Income to Non-GAAP Operating Income

Operating income, as reported

$

(2,146

)

$

65,178

$

186,095

$

120,873

Stock-based compensation

15,220

13,392

42,554

38,054

Amortization of acquisition-related intangibles and fair value adjustments

7,859

1,353

10,262

4,094

Acquisition transaction and integration costs, restructuring charges and other

11,729

11,235

26,563

18,714

Net amortization of internally developed software costs

7,071

4,272

18,201

12,894

Gain on sale of business/assets

(26,842

)

(159,753

)

(26,842

)

Non-GAAP operating income

$

39,733

$

68,588

$

123,922

$

167,787

Non-GAAP operating margin

12.8

%

20.1

%

13.5

%

17.0

%

Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes(1)

Provision for income taxes, as reported

$

475

$

15,783

$

44,588

$

22,697

Stock-based compensation

3,854

2,128

8,260

7,904

Amortization of acquisition-related intangibles and fair value adjustments

1,658

190

1,948

576

Acquisition transaction and integration costs, restructuring charges and other

712

2,587

2,794

4,437

Net amortization of internally developed software costs

1,485

897

3,822

2,708

Gain on sale of business/assets

(5,677

)

(36,759

)

(5,677

)

Tax reform charge

(2,774

)

(2,774

)

Non-GAAP provision for income taxes(1)

$

8,184

$

13,134

$

24,653

$

29,871

(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.

Reconciliation of GAAP Net (Loss) Income and Diluted EPS to Non-GAAP Net Income, Non-GAAP Diluted EPS, and EBITDA

(in thousands, except per share data, unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Net (loss) income, as reported

$

(4,622

)

$

51,644

$

138,923

$

103,555

Adjustments to reconcile net (loss) income to non-GAAP net income:

Stock-based compensation

15,220

13,392

42,554

38,054

Amortization of acquisition-related intangibles and fair value adjustments

7,980

1,477

10,625

4,379

Acquisition transaction and integration costs, restructuring charges and other

11,999

11,235

26,960

18,714

Net amortization of internally developed software costs

7,071

4,272

18,201

12,894

Gain on sale of business/assets

(26,842

)

(159,753

)

(26,842

)

Income tax effects and adjustments(1)

(7,709

)

2,649

19,935

(7,174

)

Non-GAAP net income

$

29,939

$

57,827

$

97,445

$

143,580

Non-GAAP net margin

9.7

%

17.0

%

10.6

%

14.6

%

Diluted EPS, as reported

$

(0.04

)

$

0.39

$

1.06

$

0.78

Adjustment to reconcile diluted EPS to non-GAAP diluted EPS

Stock-based compensation

0.12

0.10

0.32

0.28

Amortization of acquisition-related intangibles and fair value adjustments

0.06

0.01

0.08

0.03

Acquisition transaction and integration costs, restructuring charges and other

0.10

0.09

0.20

0.14

Net amortization of internally developed software costs

0.05

0.03

0.14

0.10

Gain on sale of business/assets

(0.20

)

(1.21

)

(0.20

)

Income tax effects and adjustments(1)

(0.06

)

0.02

0.15

(0.05

)

Non-GAAP diluted EPS

$

0.23

$

0.44

$

0.74

$

1.08

(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.

Weighted average shares outstanding - Diluted

131,419

131,889

131,671

132,890

Three Months Ended

Nine Months Ended

September 30,

September 30,

2020

2019

2020

2019

Net income, as reported

$

(4,622

)

$

51,644

$

138,923

$

103,555

Adjustments to reconcile net income to EBITDA:

Interest expense (income), net

560

(1,923

)

(2,608

)

(6,155

)

Tax expense

475

15,783

44,588

22,697

Depreciation and amortization

22,887

18,562

61,228

54,546

EBITDA

$

19,300

$

84,066

$

242,131

$

174,643

Weighted average shares outstanding - Diluted

131,419

131,889

131,671

132,890

Reconciliation of GAAP Diluted EPS to Non-GAAP Diluted EPS Guidance

(unaudited)

Three Months Ended

December 31, 2020

Low

High

GAAP Diluted EPS, guidance

$

(0.04)

$

0.10

Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:

Stock-based compensation

0.12

0.12

Amortization of acquisition-related intangibles and fair value adjustments

0.06

0.06

Acquisition transaction and integration costs, restructuring charges, and other

0.20

0.20

Net amortization of software development costs

0.04

0.04

Income tax effects and adjustments(1)

(0.06)

(0.06)

Non-GAAP Diluted EPS, guidance

$

0.32

$

0.46

(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.

Reconciliation of GAAP Revenue to Non-GAAP Revenue, Guidance

(unaudited)

Three Months Ended

December 31,

2020

2019

Percent Inc/(Dec)

(midpoint)

GAAP Revenue, guidance

$

348,000

$

367,468

(5

)%

plus: Impact of purchase accounting fair value adjustments

2,000

Non-GAAP Revenue, guidance

$

350,000

$

367,468

(5

)%

View source version on businesswire.com: https://www.businesswire.com/news/home/20201029006111/en/

Contacts

Marissa Vidaurri
Head of Investor Relations
(512) 683-5215